Latest Health News
Put a Pin in It: Acupuncture for Chronic PainAcupuncture is getting more popular because it can relieve pain – especially chronic pain – by improving circulation, regulating the nervous system, reducing inflammation, and boosting endorphins. With its potential to reduce opioid dependence, acupuncture is being seen more as a safe nondrug solution.- Online Yoga Shown to Clinically Reduce Low Back PainWith your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the chance to see if its gentle stretches and movements can provide relief.
- New Guidance for Patients Taking GLP-1 Drugs Before SurgeryAs the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
- Why This Quick At-Home Test May Be the Best Gauge of HealthMore research shows that your ability to balance on one leg can reveal how well you’re aging. Discover the fascinating science for why, and what you can do to improve.
- Misdiagnosis Is Dangerous. Help Your Doctor Get It RightThis fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to reduce the chances that a misdiagnosis will happen to you.
- Fluctuating Cholesterol Levels Linked to Dementia RiskOlder people whose cholesterol readings show big changes from one year to the next may be at an increased risk of cognitive problems as they age, including dementia.
- FDA Approves New Immunotherapy for Aggressive LeukemiaThe FDA has approved a new treatment, Aucatzyl, for a type of aggressive blood cancer called B-cell acute lymphoblastic leukemia (B-cell ALL). This treatment, a CAR T-cell immunotherapy, works by using the patient’s modified immune cells to target and kill cancer cells. Aucatzyl is designed to last longer and cause fewer side effects than similar therapies.
- New Study Finds Link Between Sleep Issues and Dementia RiskOlder adults who reported excessive daytime sleepiness and a lack of enthusiasm were more likely to develop a condition that increases the risk of dementia.
- Just 5 More Minutes of Exercise Can Lower Blood PressureNew study highlights how even small increases in physical activity can have meaningful health benefits.
- New Rosacea Treatment Option Approved by the FDAThe FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally, will be sold under the brand name Emrosi.
- New FDA Warning Added to Popular Weight Loss DrugsNew FDA Warning Added to Popular Weight Loss Drugs Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound). “This was a safety-related labeling change for the glucagon-like peptide-1 receptor agonist product class,” an FDA spokesperson said.According to the new label: “There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep
- Can New Wearable Tech Reset Your Internal Clock?New devices promise to help realign your body’s circadian rhythm for better health, but do they work? Here’s what the experts say.
- 'Forever Chemicals' Linked to Gut Health and Kidney ProblemsExposure to chemicals called PFAS during young adulthood has been linked to yet another serious health problem – reduced kidney function and kidney disease.
- Sugar in Kids' First 1,000 Days Tied to Health Risks in AdulthoodLimiting sugar intake during pregnancy and the first two years of a child’s life may lead to lifelong health benefits.
- Weight Loss Drugs May Be a New Alternative to Knee ReplacementsA new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
- FDA Fast-Tracks Asciminib for New Chronic Leukemia PatientsThe FDA has granted accelerated approval to asciminib as a first-line treatment for adults newly diagnosed with Philadelphia chromosome–positive chronic myeloid leukemia, a rare type of blood cancer.
- Can’t Shake That Cough? Walking Pneumonia Is on the RiseYoung children are increasingly being infected with bacteria that can lead to the illness known as walking pneumonia. A hallmark symptom is a cough that starts out dry, but eventually produces moderate amounts of thick, non-bloody mucus. The cough can last for weeks.
- This Familiar Gesture Might Also Be a Sign of ConcussionNew evidence suggests that rapidly shaking your head after a big hit could indicate a serious brain injury. But why do people do that, anyway?
- Marijuana in Pregnancy Tied to Kids' Attention, Anger IssuesUsing cannabis during pregnancy may have a negative impact on some areas of a child’s development. Here's what to know.
- Wait, Now Standing Desks Are Bad? What Office Workers Can DoRecent research suggests that standing won’t save you from the health harms of sitting. But before you ditch your standing desk (or your job), consider this expert advice.
- Tests, Viruses, and Advice: Navigating the New Flu Season With changing recommendations and multiple seasonal viruses to contend with, here’s your simple guide to the 2024-2025 cold and flu season and when to call your doctor.
- FDA OKs New Drug for Urinary Tract InfectionsThe FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
- Over 7,000 Bottles of Antidepressant Recalled: What to KnowThousands of bottles of the medicine duloxetine are being recalled because they may contain a potentially cancer-causing agent.
- CDC Recommends People Ages 50 to 64 Get Pneumococcal VaccinesThe CDC now says everyone 50 to 64 years old should get a pneumococcal vaccine to help protect against serious illnesses like pneumonia, meningitis, and bloodstream infections.
- New First-in-Class Drug Approved for Advanced Stomach CancerThe FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
Recommended